Dextromethorphan-induced serotonin syndrome leading to rhabdomyolysis and dialysis-requiring acute kidney injury: a case report and review

被引:0
作者
Kazuhiro Okamoto [1 ]
Nobuhiro Hashimoto [1 ]
Kaiya Ishizeki [1 ]
Takamichi Nishimura [1 ]
Shuzo Makino [1 ]
Akito Takashima [1 ]
Hiromitsu Miyakawa [1 ]
Yoshiyasu Ueda [1 ]
Terumasa Hayashi [1 ]
机构
[1] Department of Kidney Disease and Hypertension, Osaka General Medical Center, Osaka
关键词
Acute kidney injury; Dextromethorphan; Kidney replacement therapy; Rhabdomyolysis; Serotonin syndrome;
D O I
10.1186/s41100-025-00616-9
中图分类号
学科分类号
摘要
Background: Dextromethorphan (DXM) misuse, particularly among young individuals, has risen owing to its euphoric and hallucinogenic effects. High-dose DXM ingestion can trigger serotonin syndrome, a condition characterized by psychiatric, neuromuscular, and autonomic symptoms. In severe cases, serotonin syndrome may result in rhabdomyolysis and acute kidney injury (AKI). However, reports of severe DXM-induced serotonin syndrome requiring dialysis are exceedingly rare. Case presentation: We report the case of a Japanese man in his 20s who developed serotonin syndrome after consuming approximately 1800 mg of DXM. He presented with agitation, hyperthermia, and neuromuscular symptoms, fulfilling the Hunter criteria for serotonin syndrome. Despite sedation with midazolam, agitation persisted, necessitating intubation and deep sedation with propofol. The patient developed rhabdomyolysis and AKI, requiring kidney replacement therapy. Dialysis was discontinued on hospital day 20, and the patient was discharged by hospital day 26. Subsequently, 4 months after discharge, a decreased serum creatinine level of 1.04 mg/dL was detected. Conclusions: This case highlights the potential for severe, life-threatening complications, such as rhabdomyolysis and dialysis-requiring AKI, following DXM monotherapy, even in the absence of concomitant medications. Raising public awareness of the risks associated with over the counter DXM misuse is crucial, especially considering the increasing rates of overdose among young individuals. © The Author(s) 2025.
引用
收藏
相关论文
共 26 条
[1]  
Mohammad A., Muhammad A.H., Asma Y., Sajid M., Zahraa J., A mixed-methods systematic review of the prevalence, reasons, associated harms and risk-reduction interventions of over-the-counter (OTC) medicines misuse, abuse and dependence in adults, J Pharm Policy Pract, (2021)
[2]  
Peter K.G., Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity, Br J Anaesth, 95, pp. 434-441, (2005)
[3]  
Kyoko H., Noboru I., Shuhei T., Ikuko T., Katsuya Y., Risa K., Shogo K., An autopsy case of a young man with a single overdose of dextromethorphan, Leg Med, 70, (2024)
[4]  
Davies O., Batajoo S.B., Sosa P.J., Olibrice M., Full recovery after severe serotonin syndrome, severe rhabdomyolysis, multi-organ failure and disseminated intravascular coagulopathy from MDMA, Heart Lung, 43, pp. 117-119, (2014)
[5]  
Tsukasa K., Kosaku K., Minori M., Jun S., Nobutaka C., Takeshi S., Toru I., Administration of intravenous lipid emulsion for dextromethorphan poisoning with serotonin syndrome: a case report, J Pers Med, 14, (2024)
[6]  
Edward W.B., Michael S., The serotinin syndrome, N Engl J Med, 352, pp. 1112-1120, (2005)
[7]  
Zawertailo L.A., Kaplan H.L., Busto U.E., Tyndale R.F., Sellers E.M., Psychotropic effects of dextromethorphan are altered by the CYP2D6 polymorphism: a pilot study, J Clin Psychopharmacol, 18, pp. 332-337, (1998)
[8]  
Skop B.P., Finkelstein J.A., Mareth T.R., Magoon M.R., Brown T.M., The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease, Am J Emerg Med, 12, pp. 642-644, (1994)
[9]  
Michael G., Kavita M.B., Edward W.B., Serotonin syndrome in dextromethorphan ingestion responsive to propofol therapy, Pediatr Emerg Care, 23, pp. 829-831, (2007)
[10]  
Anna R.S., Anthony F.P., Daniel E.B., Dextromethorphan-induced serotonin syndrome, Clin Toxicol, 46, pp. 771-773, (2008)